Fujin Kami Pharmaceutico Llp - Company Profile

It is a pharma limited liability partnership based in Gurgaon, Haryana, India, established in 2017.
2017 Gurgaon, Haryana, India Converted To Cmp And Dissolved
Last Updated:
Access Report
About Fujin Kami Pharmaceutico Llp

Fujin Kami Pharmaceutico Llp, a converted to cmp and dissolved limited liability partnership, was established on 07 December 2017 in Gurgaon, Haryana, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAL-3402. Registered under ROC Roc Delhi. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Meenakshi (Partner), Vineet Rai (Designated Partner), Pankaj Kumar Rai (Designated Partner). Its latest date of accounts and solvency statement 31 March 2018. It is based at 3/53, Shivaji Nagar,, Gurgaon, Haryana, 122001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAL-3402

  • Incorporation Date

    07 December 2017

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Company Status

    Converted To Cmp And Dissolved

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 8 Year, 2 Months
  • Last Filing with ROC 31 Mar 2018
Company report

Fujin Kami Pharmaceutico Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Fujin Kami Pharmaceutico Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Fujin Kami Pharmaceutico Llp?
Current Designated Partners
Name Designation Appointment Date Status
Meenakshi Partner 23 Aug 2018 Current
Vineet Rai Designated Partner 07 Dec 2017 Current
Pankaj Kumar Rai Designated Partner 07 Dec 2017 Current
Charanjeet Arora Designated Partner 07 Dec 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Fujin Kami Pharmaceutico Llp.

Enhance accessibility to Fujin Kami Pharmaceutico Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Fujin Kami Pharmaceutico Llp revenue growth over time
Fujin Kami Pharmaceutico Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Fujin Kami Pharmaceutico Llp?

Unlock access to Fujin Kami Pharmaceutico Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Fujin Kami Pharmaceutico Llp?

Unlock and access historical data on people associated with Fujin Kami Pharmaceutico Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fujin Kami Pharmaceutico Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fujin Kami Pharmaceutico Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Fujin Kami Pharmaceutico Llp
Recent Activity within the Organization
  • Director Appointment

    Meenakshi was appointed as a Partner was appointed as a Partner on 23 Aug 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.

  • Annual General Meeting

    Fujin Kami Pharmaceutico Llp last Annual general meeting of members was held on 31 Mar 2018 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Fujin Kami Pharmaceutico Llp has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Delhi. was documented.

  • Director Appointment

    The activity Vineet Rai was appointed as a Designated Partner was appointed as a Designated Partner on 07 Dec 2017 & has been associated with this company since 8 years 2 months . was completed.

  • Director Appointment

    Progress on Pankaj Kumar Rai was appointed as a Designated Partner was appointed as a Designated Partner on 07 Dec 2017 & has been associated with this company since 8 years 2 months . was documented.

  • Director Appointment

    Progress on Charanjeet Arora was appointed as a Designated Partner was appointed as a Designated Partner on 07 Dec 2017 & has been associated with this company since 8 years 2 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Fujin Kami Pharmaceutico Llp?

The LLPIN of Fujin Kami Pharmaceutico Llp is AAL-3402.

Where is Fujin Kami Pharmaceutico Llp headquartered?

Fujin Kami Pharmaceutico Llp is headquartered at 3/53, Shivaji Nagar,, Gurgaon, Haryana, 122001.

When was Fujin Kami Pharmaceutico Llp incorporated?

Fujin Kami Pharmaceutico Llp was incorporated on 07 December 2017.

Who are the current directors of Fujin Kami Pharmaceutico Llp?

The current directors of Fujin Kami Pharmaceutico Llp are

What is the primary industry of Fujin Kami Pharmaceutico Llp?

The primary industry of Fujin Kami Pharmaceutico Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available